Citius Pharma (CTXR)
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-appro...
- Open
- 0.6020
- High
- 0.6099
- Low
- 0.5800
- Prev. Close
- 0.6020
- Volume
- 299.63K
- Turnover
- 176.95K
- Avg Price
- 0.5905
- Bid/Ask Ratio
- --
- Amplitude
- 4.97%
- 52wk High
- 2.1900
- Volume Ratio
- 0.33
- Turnover Ratio
- 1.47%
Citius Pharma Analyst Rating
View moreForecast & Rating
Aug 19, 2026Price forecast
$4.00580.62%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · 2 days ago, 04:30 AM
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences | CTOR Stock News
- Global Report · Aug 27 at 10:14 AM
US Mid-Caps Navigate 2026: Caesars Mega-Deal and iQIYI Pivot
- PUBT · Aug 21 at 08:15 PM
Citius Pharma wins Nasdaq extension to regain $1 minimum bid by Feb. 8, 2027
